Stocks
Editas Medicine (EDIT) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -34.8% | -61.1% | -43.9% | -176.6% | -586.6% | -2 472% | ||
| Changes by years, y/y, % | -5pp | -26pp | +17pp | -133pp | -410pp | +81.9% | |||
Editas Medicine. ROE, %
Editas Medicine. ROE, changes, pp
Editas Medicine (EDIT) ROE US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| ROE, % | ? | -1 234% | -1 485% | -586.6% | -2 472% | -70.2% | -2 472% | |
| Changes by years, y/y, % | -1 151pp | -1 366pp | -410pp | -2 069pp | +1 164pp | |||
| Changes by quarters, q/q, % | -832pp | -251pp | +899pp | -1 885pp | +2 401pp | |||
